Test of a Preventive Effect of a Deodorant Device Against Respiratory Infections (Cleverin)
|ClinicalTrials.gov Identifier: NCT00969800|
Recruitment Status : Unknown
Verified February 2010 by Taiko Pharmaceutical Co., Ltd..
Recruitment status was: Active, not recruiting
First Posted : September 1, 2009
Last Update Posted : February 4, 2010
|Condition or disease||Intervention/treatment|
|Respiratory Infection||Device: Cleverin Gel Device: Inactive Cleverin Gel|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1469 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Double-blind Sham Device-controlled Multi-center Crossover Trial of Chlorine Dioxide Gas on the Protective Effect Against Respiratory Infections|
|Study Start Date :||October 2009|
|Estimated Primary Completion Date :||March 2010|
|Estimated Study Completion Date :||April 2010|
Experimental: Active Cleverin Gel
Active Cleverin Gel, which generates chlorine dioxide gas, is placed in a room of subject.
Device: Cleverin Gel
Chlorine dioxide gas concentration at a range of 0.005 to 0.03 ppm.
Other Name: ClO2 gas generator
Sham Comparator: Inactive Cleverin Gel
Inactive Cleverin Gel is placed in a room of subject. It does not generate chlorine dioxide gas.
Device: Inactive Cleverin Gel
Seemingly same chlorine dioxide gas-generating device, but no gas is generated.
Other Name: sham ClO2 gas generator
- The number of incidence of respiratory infections [ Time Frame: Four months ]
- The incidence of adverse effects [ Time Frame: Four months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00969800
|Reifuen Nursing Home|
|Osaka, Japan, 558-0054|
|Principal Investigator:||Norio Ogata, MD, PhD||Taiko Pharmaceutical Co., Ltd.|